<DOC>
	<DOCNO>NCT00211159</DOCNO>
	<brief_summary>Memory loss difficulty think associated Alzheimer 's disease ( AD ) may due deficiency brain fatty acid name DHA . The aim trial see dietary supplementation preparation , rich DHA , halt cognitive impairment AD patient</brief_summary>
	<brief_title>OmegAD ( Omega-3 Alzheimer 's Disease )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Alzheimer 's disease MMSE 1530 , live home , treat stable dose acetylcholine esterase inhibitor &gt; 3 month remain treatment study period Already treat omega3 fatty acid , NSAIDs , warfarin , alcohol abuser , suffer serious concomitant disease caregiver</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>Dietary supplementation</keyword>
	<keyword>Cognition</keyword>
	<keyword>Safety</keyword>
</DOC>